On Friday, Co-Diagnostics Inc (NASDAQ: CODX) opened lower -4.02% from the last session, before settling in for the closing price of $0.26. Price fluctuations for CODX have ranged from $0.23 to $2.23 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -27.40%. Company’s average yearly earnings per share was noted 13.71% at the time writing. With a float of $30.68 million, this company’s outstanding shares have now reached $33.57 million.
Considering the fact that the conglomerate employs 132 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -12.25%, operating margin of -4079.44%, and the pretax margin is -3574.77%.
Co-Diagnostics Inc (CODX) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Co-Diagnostics Inc is 9.00%, while institutional ownership is 17.49%.
Co-Diagnostics Inc (CODX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 13.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.69% during the next five years compared to -27.40% drop over the previous five years of trading.
Co-Diagnostics Inc (NASDAQ: CODX) Trading Performance Indicators
Check out the current performance indicators for Co-Diagnostics Inc (CODX). In the past quarter, the stock posted a quick ratio of 4.23. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Co-Diagnostics Inc (CODX)
Compared to the last year’s volume of 0.47 million, its volume of 1.18 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 14.72%.
During the past 100 days, Co-Diagnostics Inc’s (CODX) raw stochastic average was set at 6.23%, which indicates a significant decrease from 18.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0194 in the past 14 days, which was lower than the 0.0401 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2726, while its 200-day Moving Average is $0.5989. Nevertheless, the first resistance level for the watch stands at $0.2589 in the near term. At $0.2697, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2816. If the price goes on to break the first support level at $0.2362, it is likely to go to the next support level at $0.2243. Should the price break the second support level, the third support level stands at $0.2135.
Co-Diagnostics Inc (NASDAQ: CODX) Key Stats
There are currently 33,573K shares outstanding in the company with a market cap of 8.37 million. Presently, the company’s annual sales total 3,920 K according to its annual income of -37,640 K. Last quarter, the company’s sales amounted to 50 K and its income totaled -7,530 K.
